CLINICAL_TRIALS
trial_result
· 2018-08-10
Clinical Trial Update: Vortioxetine add-on Treatment Improves the Symptoms in Patients With Bipolar Depression [Phase 2]
Summary
A Phase 2 trial evaluating vortioxetine as an add-on therapy shows improvement in symptoms for patients with bipolar depression.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Seoul National University Hospital | Conditions: Bipolar Disorder Depression | Phase 2 | Status: UNKNOWN